Justin Jordan, M.D., M.P.H.

Neurology

New Patient Appointment Accepting Virtual Visits or 214-645-8800

New Patient Appointment or 214-645-8800

See Dr. Jordan's Locations

Education & Training

Residency - Parkland Health & Hospital System (2009-2013), Neurology
Medical School - McGovern Medical School at the University of Texas Health Science Center at Houston (2005-2009)
Fellowship - Harvard Medical School/Massachusetts General Hospital (2013-2015), Neuro-oncology

Books & Publications

Publications
- Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey
  Merker VL, Ma Y, Chibnik LB, Radtke HB, Kelts K, Yohay K, Ullrich NJ, Plotkin SR, Jordan JT Orphanet Journal of Rare Diseases 2025 Dec 20
- A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations
  Gonzalez Castro LN, Gavish A, Bussema L, Mount CW, Neftel C, Nomura M, Chiocca EA, Bi WL, Arnaout O, Barker FG, Brown JM, Jordan JT, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR, Tirosh I, Suvà ML Genome Medicine 2025 Dec 17
- Bridging the Gap Between Brain Health Guidelines and Real-world Implementation
  Correa DJ, Jordan JT, Said RR CONTINUUM Lifelong Learning in Neurology 2025 Jun 31 865-884
- Principles for Novel Neurologic Therapeutics: An AAN Position Statement
  Goldstein LB, Crowe JR, Deb A, Jordan JT, Santoro JD, Sejvar JJ, Turbes M, Shapiro RE Neurology 2025 Jun 105
- ACR Appropriateness Criteria® Brain Tumors
  Author Collaboration EP, Ivanidze J, Shih RY, Utukuri PS, Ajam AA, Auron M, Chang SM, Jordan JT, Kalnins A, Kuo PH, Ledbetter LN, Pannell JS, Pollock JM, Sheehan J, Soares BP, Soderlund KA, Wang LL, Burns J Journal of the American College of Radiology 2025 May 22 S108-S135
- AAN Position: Opioids
  Najib U, Cheng EM, Halker Singh RB, Ayub N, Nelson SE, Bushard PJ, Jordan JT, Sico JJ, Turbes M, Anderson WE Neurology 2025 Apr 104
- Increased Hemorrhage During Excision of Bevacizumab-Treated NF2-Related Vestibular Schwannomas
  Wood CG, Kozanno L, Stemmer-Rachamimov A, Lee DJ, Barker FG, Carter BS, Plotkin SR, Jordan JT, Chang LS, Welling DB Laryngoscope 2025
- Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes
  Lanman TA, Youssef G, Huang R, Rahman R, Desalvo M, Flood T, Hassanzadeh E, Lang M, Lauer J, Potter C, Jiao A, Pan I, Cahill DP, Lan Z, Ospina JP, Nakhate V, Stec NE, Shi D, Bi WL, McBrayer SK, Arrillaga-Romany I, Lee EQ, Chukwueke UN, Nayak L, Forst DA, Gerstner ER, Jordan JT, Dietrich J, Miller J, Batchelor TT, Reardon DA, Wen PY, Gonzalez Castro LN Neuro-Oncology Advances 2025 Jan 7
- Reply to L. Lucchino et al. on commentary on “Histologic correlates of “Choroidal Abnormalities” in Neurofibromatosis type 1”
  Stemmer-Rachamimov AO, Kozanno L, Plotkin SR, Jordan JT, Rizzo JF Acta Neuropathologica 2024 Dec 148
- Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma
  Gupta M, Bradley JD, Massaad E, Burns EJ, Georgantas NZ, Maron GE, Batten JM, Gallagher A, Thierauf J, Nayyar N, Gordon A, Jones SA, Pisapia M, Sun Y, Jones PS, Barker FG, Curry WT, Gupta R, Romero JM, Wang N, Brastianos PK, Martinez-Lage M, Tateishi K, Forst DA, Nahed BV, Batchelor TT, Ritterhouse LL, Iser F, Kessler T, Jordan JT, Dietrich J, Meyerson M, Cahill DP, Lennerz JK, Carter BS, Shankar GM Blood 2024 Sep 144 1093-1100
- Histologic correlates of “Choroidal abnormalities” in Neurofibromatosis type 1 (NF1)
  Stemmer-Rachamimov AO, Kozanno L, Plotkin SR, Jordan JT, Rizzo JF Acta Neuropathologica 2024 Jun 147
- Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis
  Lu S, Yin Z, Chen J, Wu L, Sun Y, Gao X, Huang P, Jordan JT, Plotkin SR, Xu L Cancers 2024 Jun 16
- Neurological advocacy: Empowering the next generation of neurologists
  Tamborska AA, Jordan JT, Michael BD, Owolabi MO Journal of the Neurological Sciences 2024 May 460
- Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods
  Richey P, Funk M, Sakamoto F, Plotkin S, Ly I, Jordan J, Muzikansky A, Roberts J, Farinelli W, Levin Y, Garibyan L, Blakeley JO, Anderson RR Journal of the American Academy of Dermatology 2024 Apr 90 767-774
- Prescription Drug Prices An AAN Position Statement
  Author Collaboration AH, Santoro JD, Sico JJ, Burke JF, Sarkar K, Turbes M, Evans DA, Jordan JT Neurology 2024 Feb 102
- Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells
  Karschnia P, Arrillaga-Romany IC, Eichler A, Forst DA, Gerstner E, Jordan JT, Ly I, Plotkin SR, Wang N, Martinez-Lage M, Winter SF, Tonn JC, Rejeski K, Von Baumgarten L, Cahill DP, Nahed BV, Shankar GM, Abramson JS, Barnes JA, El-Jawahri A, Hochberg EP, Johnson PC, Soumerai JD, Takvorian RW, Chen YB, Frigault MJ, Dietrich J Neuro-oncology 2023 Dec 25 2239-2249
- Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma
  Bhattacharyya S, Oblinger JL, Beauchamp RL, Yin Z, Erdin S, Koundinya P, Ware AD, Ferrer M, Jordan JT, Plotkin SR, Xu L, Chang LS, Ramesh V Neuro-oncology 2023 Sep 25 1617-1630
- The Brain Health Imperative in the 21st Century - A Call to Action: The AAN Brain Health Platform and Position Statement
  Rost NS, Salinas J, Jordan JT, Banwell B, Correa DJ, Said RR, Selwa LM, Song S, Evans DA Neurology 2023 Sep 101 570-579
- Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients
  Ina Ly K, Richardson LG, Liu M, Muzikansky A, Cardona J, Lou K, Beers AL, Chang K, Brown JM, Ma X, Reardon DA, Arrillaga-Romany IC, Forst DA, Jordan JT, Lee EQ, Dietrich J, Nayak L, Wen PY, Chukwueke U, Giobbie-Hurder A, Choi BD, Batchelor TT, Kalpathy-Cramer J, Curry WT, Gerstner ER Clinical Cancer Research 2023 Aug 29 3017-3025
- Uniting for global brain health: Where advocacy meets awareness
  Winter SF, Walsh D, Grisold W, Jordan JT, Singhi P, Cross JH, Guekht A, Hawrot T, Destrebecq F, Feigin VL, Kariuki SM, Owolabi MO, Singh G, Dietrich J, Craven A, Amos A, Mehndiratta MM, Secco M, Baker GA, Sofia F Epilepsy and Behavior 2023 Aug 145
- Teaching NeuroImage: Subacute Quadriparesis From Intramedullary Spinal Cord Infiltrating Glioma With TERT Promoter Mutation
  Gritsch S, Aghajan Y, Kozanno L, Chiu D, Jordan JT, Frosch MP, Shankar G, Kimberly WT Neurology 2023 Jun 100 1164-1165
- Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial
  Vranceanu AM, Manglani HR, Choukas NR, Kanaya MR, Lester E, Zale EL, Plotkin SR, Jordan J, MacKlin E, Bakhshaie J JAMA Network Open 2023 Jun 6 E2320599
- Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA
  Author Collaboration Go, Cortes-Ciriano I, Steele CD, Piculell K, Al-Ibraheemi A, Eulo V, Bui MM, Chatzipli A, Dickson BC, Borcherding DC, Feber A, Galor A, Hart J, Jones KB, Jordan JT, Kim RH, Lindsay D, Miller C, Nishida Y, Proszek PZ, Serrano J, Taylor Sundby R, Szymanski JJ, Ullrich NJ, Viskochil D, Wang X, Snuderl M, Park PJ, Flanagan AM, Hirbe AC, Pillay N, Miller DT Cancer discovery 2023 Mar 13 654-671
- COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
  Banerjee J, Friedman JM, Klesse LJ, Yohay KH, Jordan JT, Plotkin SR, Allaway RJ, Blakeley JO Genetics in Medicine 2023 Feb 25
- Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients with Neurofibromatosis Type 1 Using Whole-Body MRI
  Ly KI, Merker VL, Cai W, Bredella MA, Muzikansky A, Thalheimer RD, Da JL, Orr CC, Herr HP, Morris ME, Chang CY, Harris GJ, Plotkin SR, Jordan JT Neurology 2023 Feb 100 e661-e670
- Imaging of Brain Tumors
  Klein JP, Jordan JT, Gerstner ER CONTINUUM Lifelong Learning in Neurology 2023 Feb 29 171-193
- Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2
  Jordan JT, Orr CC, Thalheimer RD, Cambillo JV, Beauchamp RL, Shaikh G, Muzikansky A, Stemmer-Rachamimov A, Giovannini M, Kalamarides M, Barker FG, Ramesh V, Plotkin SR Neuro-Oncology Advances 2023 Jan 5
- Vestibular dysfunction in neurofibromatosis type 2-related schwannomatosis
  Madhani AS, King S, Zhu J, Karmali F, Welling DB, Cai W, Jordan JT, Lewis RF Brain Communications 2023 5
- Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists
  Merker VL, Knight P, Radtke HB, Yohay K, Ullrich NJ, Plotkin SR, Jordan JT Orphanet Journal of Rare Diseases 2022 Dec 17
- Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network
  Dias-Santagata D, Heist RS, Bard AZ, Da Silva AF, Dagogo-Jack I, Nardi V, Ritterhouse LL, Spring LM, Jessop N, Farahani AA, Mino-Kenudson M, Allen J, Goyal L, Parikh A, Misdraji J, Shankar G, Jordan JT, Martinez-Lage M, Frosch M, Graubert T, Fathi AT, Hobbs GS, Hasserjian RP, Raje N, Abramson J, Schwartz JH, Sullivan RJ, Miller D, Hoang MP, Isakoff S, Ly A, Bouberhan S, Watkins J, Oliva E, Wirth L, Sadow PM, Faquin W, Cote GM, Hung YP, Gao X, Wu CL, Garg S, Rivera M, Le LP, John Iafrate A, Juric D, Hochberg EP, Clark J, Bardia A, Lennerz JK Oncologist 2022 Nov 27 930-939
- Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related pain
  Da JL, Merker VL, Jordan JT, Ly KI, Muzikansky A, Parsons M, Wolters PL, Xu L, Styren S, Brown MT, Plotkin SR Contemporary Clinical Trials 2022 Oct 121
- Understanding barriers to diagnosis in a rare, genetic disease: Delays and errors in diagnosing schwannomatosis
  Merker VL, Slobogean B, Jordan JT, Langmead S, Meterko M, Charns MP, Elwy AR, Blakeley JO, Plotkin SR American Journal of Medical Genetics, Part A 2022 Sep 188 2672-2683
- Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
  Author Collaboration IC, Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, Korf BR, Mautner VF, MacCollin M, Papi L, Rauen KA, Riccardi V, Schorry E, Smith MJ, Stemmer-Rachamimov A, Stevenson DA, Ullrich NJ, Viskochil D, Wimmer K, Yohay K, Anten M, Aylsworth A, Baralle D, Barbarot S, Barker F, Ben-Shachar S, Bergner A, Bessis D, Blanco I, Cassiman C, Ciavarelli P, Clementi M, Frébourg T, Gomes A, Halliday D, Helen Hanson Arvid Heiberg CH, Joly P, Jordan JT, Karajannis M, Kroshinsky D, Le L Genetics in Medicine 2022 Sep 24 1967-1977
- Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosis
  Burns R, Niendorf K, Steinberg K, Mueller A, Ly I, Jordan JT, Plotkin SR, Hicks SR American Journal of Medical Genetics, Part A 2022 Aug 188 2413-2420
- Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline
  Schiff D, Messersmith H, Brastianos PK, Brown PD, Burri S, Dunn IF, Gaspar LE, Gondi V, Jordan JT, Maues J, Mohile N, Redjal N, Stevens GH, Sulman EP, Van Den Bent M, Wallace HJ, Zadeh G, Vogelbaum MA Journal of Clinical Oncology 2022 May 40
- Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
  Frigault MJ, Dietrich J, Gallagher K, Roschewski M, Jordan JT, Forst D, Plotkin SR, Cook D, Casey KS, Lindell KA, Depinho GD, Katsis K, Elder EL, Leick MB, Choi B, Horick N, Preffer F, Saylor M, McAfee S, O'Donnell PV, Spitzer TR, Dey B, DeFilipp Z, El-Jawahri A, Batchelor TT, Maus MV, Chen YB Blood 2022 Apr 139 2306-2315
- Practical guidance for telemedicine use in neuro-oncology
  Strowd RE, Dunbar EM, Gan HK, Kurz S, Jordan JT, Mandel JJ, Mohile NA, Nevel KS, Taylor JW, Ullrich NJ, Welch MR, Wasilewski A, Mrugala MM Neuro-Oncology Practice 2022 Apr 9 91-104
- Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
  Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NT, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, Van Den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D Neuro-oncology 2022 Mar 24 331-357
- Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
  Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NT, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D Journal of Clinical Oncology 2022 Feb 40 492-516
- Neurofibromatoses
  Jordan JT, Plotkin SR Hematology/Oncology Clinics of North America 2022 Feb 36 253-267
- DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI
  Zhang JW, Chen W, Ina Ly K, Zhang X, Yan F, Jordan J, Harris G, Plotkin S, Hao P, Cai W IEEE Journal of Biomedical and Health Informatics 2022 Feb 26 786-797
- The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research
  Radtke HB, Klein-Tasman BP, Merker VL, Knight P, Ullrich NJ, Jordan JT, Korf B, Plotkin SR Orphanet Journal of Rare Diseases 2021 Dec 16
- Contemporary Neuroscience Core Curriculum for Medical Schools
  Author Collaboration TA, Author Collaboration TA, Gelb DJ, Kraakevik J, Safdieh JE, Agarwal S, Odia Y, Govindarajan R, Quick A, Soni M, Bickel J, Gamaldo C, Hannon P, Hatch HA, Hernandez C, Merlin LR, Noble JM, Reyes-Iglesias Y, Salas RM, Sandness DJ, Treat L, Benameur K, Brown RD, DeLuca GC, Garg N, Goldstein LB, Gutmann L, Henchcliffe C, Hessler A, Jordan JT, Kilgore SM, Khan J, Levin KH, Mohile NA, Nevel KS, Roberts K, Said RR, Simpson EP, Sirven JI, Smith AG, Southerland AM, Wilson RB Neurology 2021 Oct 97 675-684
- Opinion & Special Articles: Maximizing Inclusiveness and Diversity Through Virtual Residency Applications and Interviews
  Budhu JA, Velazquez AI, Said RR, Jordan JT Neurology 2021 Sep 97 647-650
- Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials
  Thalheimer RD, Merker VL, Ly KI, Champlain A, Sawaya J, Askenazi NL, Herr HP, Da JL, Jordan JT, Muzikansky A, Pearce EM, Sakamoto FH, Blakeley JO, Anderson RR, Plotkin SR Neurology 2021 Aug 97 S32-S41
- Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
  Author Collaboration IC, Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D, Cunha KS, Ferner R, Fisher MJ, Friedman JM, Gutmann DH, Kehrer-Sawatzki H, Korf BR, Mautner VF, Peltonen S, Rauen KA, Riccardi V, Schorry E, Stemmer-Rachamimov A, Stevenson DA, Tadini G, Ullrich NJ, Viskochil D, Wimmer K, Yohay K, Gomes A, Jordan JT, Mautner V, Merker VL, Smith MJ, Anten M, Aylsworth A, Baralle D, Barbarot S, Barker F, Ben-Shachar S, Bergner A, Bessis D, Blanco I, Cassiman C, Ciavarelli P, Clementi M, Frébourg T, Giovannini M, Halliday D, Hammond C, Hanemann CO, Le L Genetics in Medicine 2021 Aug 23 1506-1513
- A rapid genotyping panel for detection of primary central nervous system lymphoma
  Gupta M, Burns EJ, Georgantas NZ, Thierauf J, Nayyar N, Gordon A, Jones SA, Pisapia M, Sun Y, Burns RP, Velarde J, Jordan JT, Frigault MJ, Nahed BV, Jones PS, Barker FG, Curry WT, Gupta R, Batchelor TT, Romero JM, Brastianos PK, Marble HD, Martinez-Lage M, Tateishi K, Lennerz JK, Dietrich J, Cahill DP, Carter BS, Shankar GM Blood 2021 Aug 138 382-386
- Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma
  Lim-Fat MJ, Song KW, Iorgulescu JB, Andersen BM, Forst DA, Jordan JT, Gerstner ER, Reardon DA, Wen PY, Arrillaga-Romany I Journal of Neuro-Oncology 2021 May 152 515-522
- Effective provider-patient communication of a rare disease diagnosis: A qualitative study of people diagnosed with schwannomatosis
  Merker VL, Plotkin SR, Charns MP, Meterko M, Jordan JT, Elwy AR Patient Education and Counseling 2021 Apr 104 808-814
- Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
  Nayak L, Molinaro AM, Peters K, Clarke JL, Jordan JT, de Groot J, Nghiemphu L, Kaley T, Colman H, McCluskey C, Gaffey S, Smith TR, Cote DJ, Severgnini M, Yearley JH, Zhao Q, Blumenschein WM, Duda DG, Muzikansky A, Jain RK, Wen PY, Reardon DA Clinical Cancer Research 2021 Feb 27 1048-1057
- MTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition
  Beauchamp RL, Erdin S, Witt L, Jordan JT, Plotkin SR, Gusella JF, Ramesh V Journal of Biological Chemistry 2021 Jan 296
- Attracting neurology's next generation: A qualitative study of specialty choice and perceptions
  Jordan JT, Cahill C, Ostendorf T, Gutmann L, Navarro A, Gamaldo CE, Santini VE, Ali I, Soni M, Wilson RB, Said RR, Czeisler BM, Rock M, Smith AG Neurology 2020 Aug 95 E1080-E1090
- The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities
  Klesse LJ, Jordan JT, Radtke HB, Rosser T, Schorry E, Ullrich N, Viskochil D, Knight P, Plotkin SR, Yohay K Oncologist 2020 Jul 25 e1109-e1116
- Correlation between NF1 genotype and imaging phenotype on whole-body MRI NF1 radiogenomics
  Liu Y, Jordan JT, Bredella MA, Erdin S, Walker JA, Vangel M, Harris GJ, Plotkin SR, Cai W Neurology 2020 Jun 94 E2521-E2531
- Primary dural lymphomas: Clinical presentation, management, and outcome
  Karschnia P, Batchelor TT, Jordan JT, Shaw B, Winter SF, Barbiero FJ, Kaulen LD, Thon N, Tonn JC, Huttner AJ, Fulbright RK, Loeffler J, Dietrich J, Baehring JM Cancer 2020 Jun 126 2811-2820
- Genomics of mpnst (Gem) consortium: Rationale and study design for multi-omic characterization of nf1-associated and sporadic mpnsts
  Miller DT, Cortés-Ciriano I, Pillay N, Hirbe AC, Snuderl M, Bui MM, Piculell K, Al-Ibraheemi A, Dickson BC, Hart J, Jones K, Jordan JT, Kim RH, Lindsay D, Nishida Y, Ullrich NJ, Wang X, Park PJ, Flanagan AM Genes 2020 Apr 11
- Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients
  Gerstner ER, Emblem KE, Yen YF, Dietrich J, Jordan JT, Catana C, Wenchin KL, Hooker JM, Duda DG, Rosen BR, Kalpathy-Cramer J, Jain RK, Batchelor TT Neuro-Oncology Advances 2020 Jan 2
- Evaluation of peripheral nerve lesions
  Ina Ly K, Jordan JT 2020 Jan 104-117
- Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma
  Abramson JS, Irwin KE, Frigault MJ, Dietrich J, McGree B, Jordan JT, Yee AJ, Chen YB, Raje NS, Barnes JA, Davis B Cancer 2019 Nov 125 3692-3698
- First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial
  Funes CJ, Mace RA, Macklin EA, Plotkin SR, Jordan JT, Vranceanu AM Journal of Neuro-Oncology 2019 Jul 143 505-513
- Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells
  Karschnia P, Jordan JT, Forst DA, Arrillaga-Romany IC, Batchelor TT, Baehring JM, Clement NF, Nicolas Gonzalez Castro L, Herlopian A, Maus MV, Schwaiblmair MH, Soumerai JD, Takvorian RW, Hochberg EP, Barnes JA, Abramson JS, Frigault MJ, Dietrich J Blood 2019 May 133 2212-2221
- Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma
  Bale TA, Jordan JT, Rapalino O, Ramamurthy N, Jessop N, DeWitt JC, Nardi V, Alvarez MM, Frosch M, Batchelor TT, Louis DN, Iafrate AJ, Cahill DP, Lennerz JK Neuro-oncology 2019 May 21 596-605
- Characteristics of graduating US allopathic medical students pursuing a career in neurology
  Gutmann L, Cahill C, Jordan JT, Gamaldo CE, Santini V, Ali I, Soni M, Wilson RB, Said R, Czeisler BM, Smith AG Neurology 2019 Apr 92 E2051-E2063
- Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype–phenotype correlation
  Koczkowska M, Callens T, Gomes A, Sharp A, Chen Y, Hicks AD, Aylsworth AS, Azizi AA, Basel DG, Bellus G, Bird LM, Blazo MA, Burke LW, Cannon A, Collins F, DeFilippo C, Denayer E, Digilio MC, Dills SK, Dosa L, Greenwood RS, Griffis C, Gupta P, Hachen RK, Hernández-Chico C, Janssens S, Jones KJ, Jordan JT, Kannu P, Korf BR, Lewis AM, Listernick RH, Lonardo F, Mahoney MJ, Ojeda MM, McDonald MT, McDougall C, Mendelsohn N, Miller DT, Mori M, Oostenbrink R, Perreault S, Pierpont ME, Piscopo C, Pond DA, Randolph LM, Rauen KA, Rednam S, Rutledge SL, Saletti V, Schaefer GB, Schorry EK, Scott DA, Shugar A, Siqveland E, Starr LJ, Syed A, Trapane PL, Ullrich NJ, Wakefield EG, Walsh LE, Wangler MF, Zackai E, Claes KB, Wimmer K, van Minkelen R, De Luca A, Martin Y, Legius E, Messiaen LM Genetics in Medicine 2019 Apr 21 867-876
- Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: Summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines
  Chang SM, Messersmith H, Ahluwalia M, Andrews D, Brastianos PK, Gaspar LE, Gatson NT, Jordan JT, Khasraw M, Lassman AB, Maues J, Mrugala M, Raizer J, Schiff D, Stevens G, Sumrall A, Van Den Bent M, Vogelbaum MA Neuro-oncology 2019 Mar 21 424-427
- Performance of a hospital pathway for patients with a new single brain mass
  Arrillaga-Romany I, Curry WT, Jordan JT, Cahill DP, Nahed BV, Martuza RL, Loeffler JS, Järhult SJ, Muzikansky A, Cohen AB, Singhal AB, Goldstein JN, Batchelor TT Journal of oncology practice 2019 Mar 15 E211-E218
- Correction to: Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype–phenotype correlation (Genetics in Medicine, (2018), 10.1038/s41436-018-0269-0)
  Koczkowska M, Callens T, Gomes A, Sharp A, Chen Y, Hicks AD, Aylsworth AS, Azizi AA, Basel DG, Bellus G, Bird LM, Blazo MA, Burke LW, Cannon A, Collins F, DeFilippo C, Denayer E, Digilio MC, Dills SK, Dosa L, Greenwood RS, Griffis C, Gupta P, Hachen RK, Hernández-Chico C, Janssens S, Jones KJ, Jordan JT, Kannu P, Korf BR, Lewis AM, Listernick RH, Lonardo F, Mahoney MJ, Ojeda MM, McDonald MT, McDougall C, Mendelsohn N, Miller DT, Mori M, Oostenbrink R, Perreault S, Pierpont ME, Piscopo C, Pond DA, Randolph LM, Rauen KA, Rednam S, Rutledge SL, Saletti V, Schaefer GB, Schorry EK, Scott DA, Shugar A, Siqveland E, Starr LJ, Syed A, Trapane PL, Ullrich NJ, Wakefield EG, Walsh LE, Wangler MF, Zackai E, Claes KB, Wimmer K, van Minkelen R, De Luca A, Martin Y, Legius E, Messiaen LM Genetics in Medicine 2019 Mar 21 764-765
- Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: ASCO and SNO endorsement of the congress of neurological surgeons guidelines
  Chang SM, Messersmith H, Ahluwalia M, Andrews D, Brastianos PK, Gaspar LE, Gatson NT, Jordan JT, Khasraw M, Lassman AB, Maues J, Mrugala M, Raizer J, Schiff D, Stevens GD, Sumrall A, Van Den Bent M, Vogelbaum MA Journal of Clinical Oncology 2019 37 1130-1135
- Mind-Body Treatment for International English-Speaking Adults with Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial
  Vranceanu AM, Zale EL, Funes CJ, Macklin EA, McCurley J, Park ER, Jordan JT, Lin A, Plotkin SR JMIR Research Protocols 2018 Oct 7
- Genotype-targeted local therapy of glioma
  Shankar GM, Kirtane AR, Miller JJ, Mazdiyasni H, Rogner J, Tai T, Williams EA, Higuchi F, Juratli TA, Tateishi K, Koerner MV, Tummala SS, Fink AL, Penson T, Schmidt SP, Wojtkiewicz GR, Baig A, Francis JM, Rinne ML, Batten JM, Batchelor TT, Brastianos PK, Curry WT, Barker FG, Jordan JT, Iafrate AJ, Chi AS, Lennerz JK, Meyerson M, Langer R, Wakimoto H, Traverso G, Cahill DP Proceedings of the National Academy of Sciences of the United States of America 2018 Sep 115 E8388-E8394
- Increasing access to specialty care for rare diseases: A case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis
  Merker VL, Dai A, Radtke HB, Knight P, Jordan JT, Plotkin SR BMC Health Services Research 2018 Aug 18
- EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma
  Angus SP, Oblinger JL, Stuhlmiller TJ, DeSouza PA, Beauchamp RL, Witt L, Chen X, Jordan JT, Gilbert TS, Stemmer-Rachamimov A, Gusella JF, Plotkin SR, Haggarty SJ, Chang LS, Johnson GL, Ramesh V Neuro-oncology 2018 Aug 20 1185-1196
- Benign Intracranial Tumors
  Jordan JT, Plotkin SR Neurologic Clinics 2018 Aug 36 501-516
- Quality improvement in neurology: Neuro-Oncology Quality Measurement Set
  Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Leia Nghiemphu P, Smith TR, Ney DE Neuro-oncology 2018 Mar 20 531-537
- Hospice utilization in patients with malignant gliomas
  Forst D, Adams E, Nipp R, Martin A, El-Jawahri A, Aizer A, Jordan JT Neuro-oncology 2018 Mar 20 538-545
- Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: A case series
  Jordan JT, Miller JJ, Cushing T, Seijo M, Batchelor TT, Arrillaga-Romany IC, Shih HA, Nachtigall LB, Loeffler JS, Dietrich J Neuro-Oncology Practice 2018 Mar 5 64-68
- Pain correlates with germline mutation in schwannomatosis
  Jordan JT, Smith MJ, Walker JA, Erdin S, Talkowski ME, Merker VL, Ramesh V, Cai W, Harris GJ, Bredella MA, Seijo M, Suuberg A, Gusella JF, Plotkin SR Medicine (United States) 2018 Feb 97
- Quality improvement in neurology: Neuro-oncology quality measurement set
  Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DE Neurology 2018 90 652-658
- Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT
  Merker VL, McDannold S, Riklin E, Talaei-Khoei M, Sheridan MR, Jordan JT, Plotkin SR, Vranceanu AM Journal of Neuro-Oncology 2018 Jan 136 335-342
- Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations
  Dewitt JC, Jordan JT, Frosch MP, Samore WR, Iafrate AJ, Louis DN, Lennerz JK Neuro-oncology 2017 Dec 19 1640-1650
- Neurological complications of primary brain tumors
  Jordan JT, Byrne TN, Batchelor T 2017 Sep 399-416
- First report of factors associated with satisfaction in patients with neurofibromatosis
  Riklin E, Talaei-Kheoi M, Merker VL, Sheridan MR, Jordan JT, Plotkin SR, Vranceanu AM American Journal of Medical Genetics, Part A 2017 Mar 173 671-677
- Creation of an international registry to support discovery in schwannomatosis
  Ostrow KL, Bergner AL, Blakeley J, Evans DG, Ferner R, Friedman JM, Harris GJ, Jordan JT, Korf B, Langmead S, Leschziner G, Mautner V, Merker VL, Papi L, Plotkin SR, Slopis JM, Smith MJ, Stemmer-Rachamimov A, Yohay K, Belzberg AJ American Journal of Medical Genetics, Part A 2017 Feb 173 407-413
- First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis
  Talaei-Khoei M, Riklin E, Merker VL, Sheridan MR, Jordan JT, Plotkin SR, Vranceanu AM Journal of Neuro-Oncology 2017 Jan 131 413-419
- Neurologic immune-related adverse events in oncology care
  Jordan JT JAMA neurology 2016 Aug 73 907-908
- Neuroimaging in Paraneoplastic Syndromes
  Jordan JT, Vernino S 2016 Apr 811-818
- Education Research: Neurology resident education
  Jordan JT, Mayans D, Schneider L, Adams N, Khawaja AM, Engstrom J Neurology 2016 Mar 86 e112-e117
- Increased risk of cerebrovascular disease among patients with neurofibromatosis type 1: Population-based approach
  Terry AR, Jordan JT, Schwamm L, Plotkin SR Stroke 2016 Jan 47 60-65
- Glioblastoma care in the elderly
  Jordan JT, Gerstner ER, Batchelor TT, Cahill DP, Plotkin SR Cancer 2016 Jan 122 189-197
- Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies
  Field KM, Jordan JT, Wen PY, Rosenthal MA, Reardon DA Cancer 2015 Apr 121 997-1007
- Novel chemotherapeutic approaches in adult high-grade gliomas
  Jordan JT, Wen PY Cancer treatment and research 2015 163 117-142
- A high-throughput kinome screen reveals serum/glucocorticoidregulated kinase 1 as a therapeutic target for NF2-deficient meningiomas
  Beauchamp RL, James MF, DeSouza PA, Wagh V, Zhao WN, Jordan JT, Stemmer-Rachamimov A, Plotkin SR, Gusella JF, Haggarty SJ, Ramesh V Oncotarget 2015 6 16981-16997
- Magnetic resonance imaging observations in primary central nervous system lymphoma
  Jordan JT, Plotkin S, Dietrich J JAMA neurology 2014 Jul 71 918-919
- Teaching NeuroImages: Brain mass with hilar adenopathy The importance of histologic diagnosis
  Jordan JT, Yang HS, Narendra D, Plotkin SR Neurology 2014 May 82 e161-e162
- International issues: Obtaining an adult neurology residency position in the United States: An overview
  Jordan JT, Sellner J, Struhal W, Schneider L, Mayans D Neurology 2014 Apr 82 e112-e115
- Unrecognized cobalamin deficiency, nitrous oxide, and reversible subacute combined degeneration
  Jordan JT, Weiser J, Van Ness PC Neurology: Clinical Practice 2014 4 358-361
- Topotecan enhances immune clearance of gliomas
  Wei J, DeAngulo G, Sun W, Hussain SF, Vasquez H, Jordan J, Weinberg J, Wolff J, Koshkina N, Heimberger AB Cancer Immunology, Immunotherapy 2009 Feb 58 259-270
- Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy
  Jordan JT, Sun W, Hussain SF, DeAngulo G, Prabhu SS, Heimberger AB Cancer Immunology, Immunotherapy 2008 Jan 57 123-131
- Erratum: Preferential migration of regulatory T cells mediated by gliomasecreted chemokines can be blocked with chemotherapy (Cancer Immunology, Immunotherapy DOI: 10.1007/s00262-007-0336-x)
  Jordan JT, Sun W, Hussain SF, DeAngulo G, Prabhu SS, Heimberger AB Cancer Immunology, Immunotherapy 2008 Jan 57 133
- A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients
  Hussain SF, Kong LY, Jordan J, Conrad C, Madden T, Fokt I, Priebe W, Heimberger AB Cancer research 2007 Oct 67 9630-9636

Articles by Dr. Jordan

Brain; ENT; Patient Stories

NF2-related schwannomatosis: Supporting patients with rare hearing nerve tumors

Laura Klesse, M.D., Ph.D.
Justin Jordan, M.D., M.P.H.
J. Walter Kutz, M.D.

November 18, 2025

New Patient Appointment Accepting Virtual Visits or 214-645-8800

Justin Jordan, M.D., M.P.H.

Education & Training

Books & Publications

Articles by Dr. Jordan

NF2-related schwannomatosis: Supporting patients with rare hearing nerve tumors

Neuro-Oncology Clinic